Trial NCT05074433

View at ClinicalTrials.gov 
Org. Study IDs: R10933-10987-COV-2176
Secondary IDs: 2021-005222-14

Last trial update was posted on 2023-07-24

MeSH Interventions

Casirivimab and imdevimab drug combination

MeSH Conditions

COVID-19

Other Conditions

Immunocompromised

Stopping Reasons

Emerging SARS-CoV2 variants impacting susceptibility to study drug

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID